etomoxir has been researched along with Allergic Encephalomyelitis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Bockermann, R; Corthals, A; Issazadeh-Navikas, S; Kwon, TH; Larsen, A; Mørkholt, AS; Nieland, JDV; Nieland, JGK; Nielsen, S; Oklinski, MK | 1 |
Gopalasingam, G; Kastaniegaard, K; Larsen, A; Mørkholt, AS; Nieland, JD; Nielsen, S; Niganze, W; Stensballe, A; Trabjerg, MS | 1 |
2 other study(ies) available for etomoxir and Allergic Encephalomyelitis
Article | Year |
---|---|
Pharmacological inhibition of carnitine palmitoyl transferase 1 inhibits and reverses experimental autoimmune encephalitis in rodents.
Topics: Animals; Brain; Carnitine O-Palmitoyltransferase; Encephalomyelitis, Autoimmune, Experimental; Enzyme Inhibitors; Epoxy Compounds; Female; Interleukin-17; Interleukin-4; Mice; Mice, Inbred C57BL; Myelin Sheath; Rats; Rats, Inbred Lew | 2020 |
Identification of brain antigens recognized by autoantibodies in experimental autoimmune encephalomyelitis-induced animals treated with etomoxir or interferon-β.
Topics: Animals; Autoantibodies; Autoantigens; Autoimmunity; Brain; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Epoxy Compounds; Female; Immunoprecipitation; Interferon-beta; Multiple Sclerosis; Rats; Severity of Illness Index | 2018 |